Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Director/PDMR Shareholding

20 Oct 2011 16:47

RNS Number : 5742Q
BowLeven Plc
20 October 2011
 

20 October 2011

 

Bowleven plc ("Bowleven" or the "Company")

 

Directors' interests

 

The Company announces that on 19 October 2011, pursuant to a conditional placing of 77,500,000 new ordinary shares in the capital of the Company at a placing price of 103 pence each, the following dealings (direct or indirect) by directors of Bowleven took place (in accordance with a derogation granted to the Company in respect of AIM rule 21) pursuant to the conditional placing:-

 

Ronnie Hanna, Non-Executive Chairman of the Company, has agreed to subscribe for 20,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Ronnie Hanna's total beneficial shareholding in the Company will be 330,125 shares which at that time will represent approximately 0.11% of the then enlarged issued share capital of the Company.

 

Kevin Hart, Chief Executive Officer of the Company, has agreed to subscribe for 200,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Kevin Hart's total beneficial shareholding in the Company will be 2,190,000 shares which at that time will represent approximately 0.75% of the then enlarged issued share capital of the Company.

 

John Brown, Finance Director of the Company, has agreed to subscribe for 25,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, John Brown's total beneficial shareholding in the Company will be 122,675 shares which at that time will represent approximately 0.04% of the then enlarged issued share capital of the Company.

 

Ed Willett, Exploration Director of the Company has agreed to subscribe for 25,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Ed Willett's total beneficial shareholding in the Company will be 217,235 shares which at that time will represent approximately 0.07% of the then enlarged issued share capital of the Company.

 

Peter Wilson, Director and General Counsel of the Company, has agreed to subscribe for 25,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Peter Wilson's total beneficial shareholding in the Company will be 277,119 shares which at that time will represent approximately 0.09% of the then enlarged issued share capital of the Company.

 

Tim Sullivan, Non-Executive Director of the Company, has agreed to subscribe for 50,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Tim Sullivan's total beneficial shareholding in the Company will be 146,745 shares which at that time will represent approximately 0.05% of the then enlarged issued share capital of the Company.

 

The allotment of the new ordinary shares pursuant to the conditional placing is subject to, amongst other things, the required shareholder approval to be sought at the Company's General Meeting being held on Monday 7 November 2011.

 

ENQUIRIES

For further information please contact:

 

Bowleven plc

Kevin Hart, Chief Executive

00 44 131 524 5678

Kerry Crawford, Head of Investor Relations

BofA Merrill Lynch

00 44 207 628 1000

Andrew Osborne

Tony White

Brunswick Group LLP

Patrick Handley

00 44 207 404 5959

Natalia Erikssen

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPGGQCUUPGGAU
Date   Source Headline
8th Dec 202111:53 amRNSRESULT OF ANNUAL GENERAL MEETING
15th Nov 20217:00 amRNSPosting of Annual Report and Accounts 2021
10th Nov 202111:05 amRNSSecond Price Monitoring Extn
10th Nov 202111:00 amRNSPrice Monitoring Extension
10th Nov 20217:00 amRNSFull Year Results
9th Nov 20218:55 amRNSBlock Admission Six Monthly Return
20th Aug 20214:41 pmRNSSecond Price Monitoring Extn
20th Aug 20214:36 pmRNSPrice Monitoring Extension
20th Aug 20212:05 pmRNSSecond Price Monitoring Extn
20th Aug 20212:00 pmRNSPrice Monitoring Extension
20th Aug 202111:05 amRNSSecond Price Monitoring Extn
20th Aug 202111:00 amRNSPrice Monitoring Extension
20th Aug 20219:05 amRNSSecond Price Monitoring Extn
20th Aug 20219:00 amRNSPrice Monitoring Extension
24th May 20212:06 pmRNSSecond Price Monitoring Extn
24th May 20212:00 pmRNSPrice Monitoring Extension
14th May 202111:05 amRNSSecond Price Monitoring Extn
14th May 202111:00 amRNSPrice Monitoring Extension
13th May 202111:06 amRNSSecond Price Monitoring Extn
13th May 202111:00 amRNSPrice Monitoring Extension
10th May 20219:15 amRNSBlock Admission Six Monthly Return
30th Mar 20212:05 pmRNSSecond Price Monitoring Extn
30th Mar 20212:01 pmRNSPrice Monitoring Extension
30th Mar 20219:05 amRNSSecond Price Monitoring Extn
30th Mar 20219:00 amRNSPrice Monitoring Extension
30th Mar 20217:00 amRNSInterim Results
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20219:05 amRNSSecond Price Monitoring Extn
16th Mar 20219:00 amRNSPrice Monitoring Extension
3rd Mar 20217:00 amRNSHolding(s) in Company
12th Feb 202111:06 amRNSSecond Price Monitoring Extn
12th Feb 202111:00 amRNSPrice Monitoring Extension
27th Jan 20215:50 pmRNSTR-1: Notification of major holdings
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSEtinde Exploitation Authorisation Agreement
11th Jan 20217:00 amRNSAppointment of Chairman
31st Dec 202012:35 pmRNSPrice Monitoring Extension
30th Dec 20204:41 pmRNSSecond Price Monitoring Extn
30th Dec 20204:36 pmRNSPrice Monitoring Extension
17th Dec 20204:36 pmRNSPrice Monitoring Extension
16th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 202011:06 amRNSResult of Annual General Meeting
30th Nov 20204:41 pmRNSSecond Price Monitoring Extn
30th Nov 20204:36 pmRNSPrice Monitoring Extension
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
24th Nov 20204:40 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.